Fentazin

Quick links to important sections

Fentazin

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fentazin

Property Description
Active ingredient Perphenazine
Forms Tablet, Oral Solution, Injectable Solution
Pharmacological class Typical Antipsychotic (Phenothiazine)
Common purpose Stabilizing mental state and controlling severe nausea
Origin Synthetic

Fentazin is a pharmaceutical preparation containing the single active ingredient, Perphenazine. This compound is formally classified as a Phenothiazine Antipsychotic, which means it belongs to the class of typical antipsychotics, a historical term for first-generation agents. Perphenazine is a synthetic small molecule, manufactured and not derived from natural sources. This classification is central to the drug's fundamental function, which is defined by its action as a dopamine receptor antagonist in the central nervous system.

The active substance, Perphenazine, is manufactured in several distinct preparations, primarily including the common oral tablet, a liquid oral solution, and an injectable solution for parenteral administration. The clinical utility of Fentazin stems from its dual therapeutic properties: its primary use in the stabilization of mental symptoms and its secondary role for the control of severe nausea and vomiting in adults. The medication is used to help control severe, debilitating vomiting. This significant antiemetic activity distinguishes Perphenazine from certain other antipsychotics, making it valuable in clinical scenarios where controlling vomiting is a necessity alongside its primary neurological purpose.

The fundamental function of Fentazin is achieved by its primary mechanism of modulating specific brain chemicals, mainly through antagonism of dopamine D2 receptors. This action helps to restore a functional balance in chemical messaging pathways, which translates clinically into a reduction in agitation and the promotion of clearer thinking. Perphenazine has a sustained role in managing psychiatric conditions and is an established, potent antipsychotic agent. This medication has an established history of helping to stabilize profound mental and emotional distress.

What side effects are possible with Fentazin?

Possible side effects and safety information

The official safety profile for Fentazin (Perphenazine) is categorized by government regulatory bodies based on the frequency and system-organ class of reported events. As a typical antipsychotic, the safety characteristics are primarily defined by neurological and systemic effects.


Adverse Reaction Classification

Common Adverse Reactions

Adverse reactions frequently reported in official documents include drowsiness, dizziness, blurred vision, dry mouth, and constipation. Movement disturbances, known as Extrapyramidal Reactions (such as Dystonia and Pseudoparkinsonism), are also commonly listed safety concerns, particularly at the initiation of treatment or during dose increases.

System-Organ Classes Involved

The most frequently impacted systems noted in regulatory labeling include Nervous System Disorders, Cardiac Disorders (e.g., orthostatic hypotension and ECG changes like Q-T prolongation), Endocrine Disorders (e.g., hyperprolactinemia), and Gastrointestinal Disorders.


Serious Safety Concerns and Restrictions

Regulatory documents highlight several serious, less common adverse reactions. These include Neuroleptic Malignant Syndrome (NMS), a rare but critical syndrome, and Tardive Dyskinesia (TD), a potentially irreversible movement disorder associated with long-term exposure. Hematological risks such as Agranulocytosis are also documented.

Official labeling carries a high-level safety constraint regarding specific populations: the drug is not approved for use in older patients with dementia-related psychosis due to a documented increased risk of mortality. Furthermore, the medicine is generally contraindicated in conditions such as severe central nervous system depression, comatose states, or the presence of established blood dyscrasias.

Overdose and Emergency Response

Fentazin Overdose and When to Seek Help

Overdosage of Perphenazine (Fentazin) presents with severe manifestations primarily affecting the Central Nervous System and cardiovascular function. Documented signs include CNS depression ranging from lethargy to coma and difficulty responding to surroundings. Neurological effects may also manifest as seizures or extrapyramidal reactions. Cardiovascularly, an overdose may cause a fast or irregular heartbeat and significant hypotension (low blood pressure).

Immediate Medical Attention is Required when the individual displays critical, life-threatening symptoms. Regulatory documents mandate calling emergency services (911) immediately if the victim has collapsed, has trouble breathing, or cannot be awakened. Contacting the poison control helpline is also required for immediate guidance.

Management is symptomatic and supportive, as no specific antidote is known. The official response includes securing the airway, initiating gastric decontamination (e.g., lavage and activated charcoal), and controlling seizures with benzodiazepines. Continuous cardiac monitoring (ECG) is necessary for a minimum of six hours. A critical regulatory constraint for managing associated hypotension is that epinephrine must not be administered. Management principles for pediatric patients are generally similar to those for adults.

Therapeutic Uses of Fentazin

Fentazin (Perphenazine) is applied in situations involving certain distressing symptoms across two distinct therapeutic domains, generally offering supportive relief when symptoms become more noticeable.

Perphenazine is commonly used to help with two primary therapeutic domains: managing symptoms related to psychotic disorders, including acute and chronic schizophrenia, and assisting with severe nausea and vomiting in adults.


Stabilization of Severe Symptoms

This medication is applied in conditions associated with acute or disruptive episodes of mental and emotional distress. It is used to address pronounced symptoms like delusions, hallucinations, and severe agitation, which create noticeable interference with daily stability. Providing symptomatic relief offers support that helps ease the overall symptom burden, which may assist with maintaining functional stability during symptomatic periods.

“The medication is commonly used when short-term symptomatic assistance is needed, supporting the patient during difficult episodes.”


Control of Intense Physical Distress

Fentazin is commonly used across contexts where additional symptomatic support is needed to address severe, debilitating nausea and persistent vomiting in adults. This antiemetic activity is relevant in contexts involving heightened systemic burden where symptoms interfere with daily comfort. By easing these distressing physical manifestations, the medication supports patients during episodes of heightened discomfort and may assist with maintaining functional stability.

Quick Fact: Relief for Severe Nausea and Vomiting

Regulatory References

  1. NIH DailyMed

Eligibility and Restrictions for Use

Who can and cannot use Fentazin?

Regulatory documents strictly define the population groups eligible and ineligible for Fentazin (Perphenazine) use.

Category Regulatory Status Description
Populations Contraindicated Contraindicated Use is prohibited in patients who are comatose or severely obtunded, and those taking large doses of CNS depressants (e.g., alcohol, narcotics). Contraindications also include patients with liver damage, blood dyscrasias, bone marrow depression, or suspected subcortical brain damage.
Age-Related Eligibility Not Recommended/Not Approved The medicine is not recommended for children under 12 years of age. It is not approved for elderly patients with dementia-related psychosis, a population with a documented increased risk of mortality (Boxed Warning).
Reproductive Status Safe Use Not Established Safe use has not been established during pregnancy or lactation. Neonates exposed during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms.
Conditional Use Use with Caution Caution is advised for patients with convulsive disorders (due to lowered convulsive threshold) or psychic depression.

These official regulatory statements define absolute exclusions and mandatory restrictions, ensuring the medicine is used only within labeled population guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fentazin (perphenazine) can interact with numerous other medicines, posing risks such as increased sedation, low blood pressure, and severe cardiac issues. Due to its metabolism by the liver enzyme CYP2D6, drugs that inhibit this enzyme can lead to significantly higher levels of perphenazine in the body, increasing the risk of adverse effects.

Key Interacting Product Categories

Product Category Clinical Relevance Primary Risk/Mechanism
CNS Depressants (e.g., alcohol, opioids, barbiturates, general anesthetics, antihistamines) Contraindicated/Major Additive central nervous system (CNS) depression, profound sedation, respiratory depression, and hypotension.
Drugs that prolong the QT interval (e.g., certain antiarrhythmics, tricyclic antidepressants, other antipsychotics) Major/Avoid Increased risk of serious heart rhythm problems (Torsade de Pointes and other arrhythmias).
Anticholinergics (e.g., atropine, certain antihistamines) Monitor Closely Potentiation of anticholinergic effects like dry mouth, constipation, and urinary retention.
CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, sertraline) Monitor Closely Increased plasma concentrations and potential toxicity of Fentazin due to reduced metabolism.

Other Important Interactions

  • Epinephrine should not be administered to treat drug-induced hypotension, as its action is blocked and potentially reversed by perphenazine, which may worsen the low blood pressure. Norepinephrine is the recommended vasopressor.
  • Anticonvulsants may require increased dosage when co-administered with Fentazin, as phenothiazines can lower the seizure threshold.
  • Products that induce photosensitivity (e.g., aminolevulinic acid) should be avoided due to the additive risk of severe skin reactions.
  • The use of alcohol is strongly discouraged due to additive CNS depression and the risk of severe hypotension.

Mechanism of Action

Fentazin (perphenazine) exerts its effects by engaging mechanisms that modulate dysregulated processes in the central nervous system. Its action involves two primary mechanistic domains: targeted neurotransmitter modulation and broader systems-level adjustments.

Targeting Dopamine Pathways

This domain covers the drug's primary action as an antagonist (blocker) at post-synaptic dopamine D2 receptors. By initiating this specific signaling suppression, the drug contributes to the reduction of excessive pathway activity within core neural circuits, resulting in decreased signal transduction from the dopamine mediator.

Multi-Receptor System Modulation

This domain addresses the drug's influence on multiple other receptors, including alpha-1 adrenergic, histamine H1, and certain serotonin (5-HT2A) receptors. This modulation results in altered signal dynamics within targeted pathways, leading to altered downstream activity including central nervous system depressant effects and inhibition of signaling from the Chemoreceptor Trigger Zone (CTZ) due to D2 antagonism in that area.

Dosage and Administration Information

Administration Overview

Fentazin (perphenazine) is an oral medication typically available in tablet form. It is intended for regular use as directed by a healthcare provider to maintain consistent levels of the medication in the bloodstream. The tablets are generally taken with a full glass of water and can be consumed with or without food, though taking them with food may help reduce potential stomach upset.

Handling and Storage

Proper handling of the medication is necessary to maintain its stability. Tablets should be kept in their original container, away from excessive heat, moisture, and direct light. It is recommended to store the medication at room temperature in a secure location.

Consistency in Use

Effective management of symptoms with Fentazin relies on consistent administration. Establishing a daily routine can assist in ensuring the medication is taken at the same time each day. If the medication is used in a liquid concentrate form, it requires specific dilution with compatible liquids such as water, carbonated beverages, or certain fruit juices immediately before consumption.

Monitoring Treatment

Treatment with Fentazin often requires periodic evaluation by a healthcare professional to monitor the body's response. Adjustments to the treatment plan are made based on individual progress and clinical observation over time. It is important to continue the regimen as established, even if symptoms appear to improve, until otherwise advised by a medical professional.

Recent Clinical Evidence

Recent Clinical Evidence Summary

Fentazin (Perphenazine) is classified as a first-generation or typical antipsychotic medication. Research has primarily focused on its use in managing schizophrenia and its profile compared to newer drug classes.

Key Findings in Schizophrenia Treatment

  • Symptom Management: Studies have evaluated Fentazin's association with the management of positive symptoms of schizophrenia, such as hallucinations and delusions. Findings regarding its effects on negative symptoms (e.g., lack of motivation, flattened affect) have historically been less clear.
  • Comparative Effectiveness: Recent large-scale studies examined whether Fentazin's overall effectiveness was different from that of second-generation (atypical) antipsychotics. Some analyses have suggested that Fentazin had effects similar to several other antipsychotic drugs for overall mental and global state outcomes. However, the quality of evidence supporting these precise comparisons is often described as very low due to variations in study design and reporting.

Tolerability and Side Effect Profile

Fentazin's safety profile has been a major focus of research, particularly concerning motor side effects:

  • Extrapyramidal Symptoms (EPS): The drug's profile is associated with extrapyramidal adverse effects (e.g., dystonia, Parkinson-like symptoms) at a rate similar to other medium-potency typical antipsychotics and some atypical agents.
  • Long-Term Follow-up: The drug's tolerability during long-term use has been monitored, tracking the incidence of adverse events over extended periods. This research is crucial for evaluating its suitability as a maintenance therapy.

Mechanism of Action Focus

According to research, Fentazin's primary therapeutic action is believed to involve the antagonism of dopamine D2 receptors in the central nervous system. This mechanism is central to its effects on symptoms of psychosis.

Key Studies & References

  1. Antipsychotic drugs for the acute treatment of schizophrenia: a comparative effectiveness review
  2. NICE Guideline: Psychosis and Schizophrenia in Adults: Prevention and Management

Frequently Asked Questions (FAQ)

Common questions about Fentazin (FAQ)


Q: How quickly does Fentazin start to work after the first dose?

Studies and official information indicate that the full development of benefits for managing certain mental health conditions happens over time. Initial changes in symptoms are often noted within approximately one to two weeks of starting treatment. Continued improvements often occur gradually over four to six weeks.

Q: Is it common to feel very sleepy when starting Fentazin?

Yes, drowsiness is described in official documents as a commonly reported adverse reaction. This effect typically occurs within the first one to two weeks after beginning treatment. The feeling of sleepiness may gradually lessen as treatment continues for some individuals.

Q: Can Fentazin affect my ability to drive?

Regulatory documents advise that the medicine can affect a person's alertness or coordination due to side effects like dizziness or drowsiness. Official guidance notes that caution is advised when performing tasks that require alertness, such as driving or operating machinery.

Q: Are there any long-term effects of taking Fentazin?

Official safety documents highlight that long-term use is associated with the potential for Tardive Dyskinesia. This is a movement disorder that could become irreversible. Patients prescribed the medication for extended periods are typically monitored, as noted in official guidance.

Q: Does Fentazin make you more sensitive to the sun?

Yes, regulatory sources note that Fentazin may increase your sensitivity to light, a condition sometimes called photosensitivity. Other documented effects include potential changes in skin color. Official guidance notes that protecting skin from sun exposure may be appropriate while using this medication.

Q: Is Fentazin safe for elderly patients?

The medicine is not approved for use in older patients who have dementia-related psychosis due to a documented increased risk of death in this specific group. For other conditions, official instructions state that the starting doses for elderly or debilitated patients are generally lower than the standard adult dose.

Q: How does Fentazin's mechanism differ from newer drugs?

Fentazin is classified as a first-generation (typical) antipsychotic. Its primary therapeutic action is strongly focused on blocking specific dopamine receptors in the brain. This class of medication is described as being associated with movement-related side effects, which differs from the mechanisms of some newer agents.

Q: Does Fentazin cause weight gain?

Yes, official adverse event reporting lists weight gain as a documented side effect of the medicine. Regulatory documents track changes in body weight (both increases and decreases) as metabolic adverse effects during treatment.

Q: Can Fentazin be taken with over-the-counter pain relief?

Regulatory information indicates that combining Fentazin with other medications can increase the risk of central nervous system (CNS) depression. This category includes some components found in over-the-counter pain relief. Official guidance emphasizes the need to disclose all current medications, including non-prescription products, to the prescribing healthcare provider.

Q: How long does Fentazin stay in your system?

Pharmacokinetic studies indicate that the average terminal half-life of the active ingredient, perphenazine, is approximately 9 to 12 hours. The half-life is the time it takes for half of the drug to be eliminated from the body.

Q: Can Fentazin interact with herbal supplements?

Official guidance advises patients to inform their healthcare provider about all medications, herbal products, and other supplements they may be using. A full review of all products is necessary due to the potential for unforeseen interactions.

Q: What is the purpose of the different strengths Fentazin comes in?

The drug is manufactured in different strengths (e.g., 2 mg, 4 mg, 8 mg, 16 mg tablets). This variety is intended to allow for the highly individualized dosing necessary for different medical conditions and patient groups, such as allowing for a lower starting dose in certain populations.

Q: Is Fentazin associated with any changes in heart rhythm?

Regulatory safety documents state that Fentazin has been associated with reports of ventricular arrhythmias and a rare heart rhythm problem called QT prolongation. Due to these potential effects, the drug is used with caution in patients with pre-existing heart conditions.

Q: Is Fentazin used for anxiety or just psychosis?

The primary approved uses for Fentazin are for schizophrenia and severe nausea/vomiting. However, the active ingredient is also available in a combination medication with an antidepressant (amitriptyline) specifically indicated for the treatment of moderate-to-severe anxiety and depression.

Q: Does Fentazin interact with birth control pills?

Official safety documentation notes that the medicine can cause endocrine system effects, such as disturbances in the menstrual cycle. While it does not specifically list oral contraceptives as a formal drug-drug interaction, regulatory documentation notes the potential for endocrine effects.

Q: Is it possible to take Fentazin with anti-anxiety medicine?

Regulatory documents state that Fentazin is contraindicated (prohibited) in patients taking large doses of CNS depressants. This category includes many anti-anxiety and sedative medications, as combination use carries an increased risk of sedation and respiratory depression.

Q: Can Fentazin cause confusion or memory problems?

Yes, official adverse reaction reports include instances of confusion and altered mental status. Specifically, nocturnal confusion has been documented, and altered mental status can be a symptom of the serious condition Neuroleptic Malignant Syndrome.

Q: Is Fentazin a controlled substance?

Official US government classifications state that the active substance, perphenazine, is not a controlled drug under the Controlled Substances Act (CSA) Schedule. It is categorized as a prescription-only medicine.

Q: Do studies show Fentazin can affect cholesterol levels?

Yes, postmarketing surveillance reports have documented an association between Fentazin use and changes in metabolic markers. This includes reports of increased serum cholesterol levels as a potential adverse effect.

Q: Does taking Fentazin require any special precautions before surgery?

Official warnings note that the use of Fentazin with medications given during surgery or dental procedures may increase central nervous system (CNS) depressant effects. Official warnings recommend informing medical staff of treatment before any procedure.

Q: Is it true that Fentazin can be used to treat hiccups?

Yes, official labeling and regulatory information confirm that the drug has an indication for the management of severe hiccups in adults. This application typically involves the injectable form of the medicine.

Q: Is Fentazin available over the counter in any country?

Official global classifications state that Fentazin (perphenazine) is categorized as a prescription-only medicine (Rx). It is not available for purchase over the counter in any major regulatory jurisdiction.

Q: Are there any known drug-drug interactions with Fentazin and stomach acid reducers?

Yes, official documentation describes an interaction with antacids and certain other stomach acid reducers. These products can cause a decrease in the absorption of Fentazin, which may lead to lower drug concentration in the body and potentially reduce its effectiveness.

Q: Why is Fentazin sometimes used in combination with other drugs?

Official documents describe Fentazin being used in combination with other therapeutic agents, such as the antidepressant amitriptyline. This is typically done to address co-morbid conditions, such as mental health issues characterized by a mixture of anxiety, agitation, and depressive symptoms.

How should Fentazin be stored and disposed of?

How to Store and Dispose of Fentazin (Perphenazine)

The official storage conditions for Fentazin (perphenazine) tablets require adherence to specific temperature and environmental constraints to maintain product stability.

Fentazin must be stored at controlled room temperature, which is defined as 20 C to 25 C (68 F to 77 F). The product must not be stored above 25 C (77 F) and should be protected from light.

Packaging and Safety

  • Keep the medicine in its original container to maintain protection from moisture.
  • The product must be stored out of the reach and sight of children.

Disposal

Any unused or expired medicinal product or waste material must be disposed of in accordance with local requirements. The product should not be allowed to enter sewers or surface water, aligning with environmental handling guidelines for its active substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fentazin found in:

A-Z Index: